ATE86965T1 - Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie. - Google Patents

Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.

Info

Publication number
ATE86965T1
ATE86965T1 AT88904245T AT88904245T ATE86965T1 AT E86965 T1 ATE86965 T1 AT E86965T1 AT 88904245 T AT88904245 T AT 88904245T AT 88904245 T AT88904245 T AT 88904245T AT E86965 T1 ATE86965 T1 AT E86965T1
Authority
AT
Austria
Prior art keywords
pct
treatment
adrenoleucodystrophy
pharmaceutical compositions
date sep
Prior art date
Application number
AT88904245T
Other languages
English (en)
Inventor
Donald Suddaby
Keith Coupland
Original Assignee
Croda Int Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10632210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE86965(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Croda Int Plc filed Critical Croda Int Plc
Application granted granted Critical
Publication of ATE86965T1 publication Critical patent/ATE86965T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/48—Separation; Purification; Stabilisation; Use of additives
    • C07C67/52—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation
    • C07C67/54—Separation; Purification; Stabilisation; Use of additives by change in the physical state, e.g. crystallisation by distillation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/533—Monocarboxylic acid esters having only one carbon-to-carbon double bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT88904245T 1988-02-23 1988-05-13 Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie. ATE86965T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888804188A GB8804188D0 (en) 1988-02-23 1988-02-23 Pharmaceutical compositions
EP88904245A EP0360821B1 (de) 1988-02-23 1988-05-13 Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie
PCT/GB1988/000373 WO1989008095A1 (en) 1988-02-23 1988-05-13 Pharmaceutical compositions for treating adrenoleukodystrophy

Publications (1)

Publication Number Publication Date
ATE86965T1 true ATE86965T1 (de) 1993-04-15

Family

ID=10632210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904245T ATE86965T1 (de) 1988-02-23 1988-05-13 Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.

Country Status (10)

Country Link
US (1) US5331009A (de)
EP (1) EP0360821B1 (de)
JP (1) JPH0667869B2 (de)
AT (1) ATE86965T1 (de)
CA (1) CA1308028C (de)
DE (1) DE3879489T2 (de)
DK (1) DK521389A (de)
GB (1) GB8804188D0 (de)
NO (1) NO894083L (de)
WO (1) WO1989008095A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9416846D0 (en) * 1994-08-19 1994-10-12 Croda Int Plc Lipid supplementation
WO2000018394A1 (en) 1998-09-28 2000-04-06 The Johns Hopkins University Adrenoleukodystrophy treatments and drug screening
JP2001278786A (ja) * 2000-03-29 2001-10-10 Morinaga Milk Ind Co Ltd 高尿酸性疾患予防治療剤
AU2015285212A1 (en) 2014-07-02 2017-01-12 Nippon Suisan Kaisha, Ltd Production method of marine product-derived free monounsaturated fatty acids or lower alcohol esters thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4442125A (en) * 1978-06-26 1984-04-10 Oxford Hill, Ltd. Process for detaching or preventing attachment of microorganisms to a surface
US4377526A (en) * 1981-05-15 1983-03-22 Nippon Suisan Kaisha, Ltd. Method of purifying eicosapentaenoic acid and its esters
US4843095A (en) * 1987-08-07 1989-06-27 Century Laboratories, Inc. Free fatty acids for treatment or propyhlaxis of rheumatoid arthritis arthritis

Also Published As

Publication number Publication date
DK521389D0 (da) 1989-10-20
DE3879489T2 (de) 1993-06-24
JPH0667869B2 (ja) 1994-08-31
EP0360821B1 (de) 1993-03-17
EP0360821A1 (de) 1990-04-04
CA1308028C (en) 1992-09-29
US5331009A (en) 1994-07-19
NO894083D0 (no) 1989-10-12
NO894083L (no) 1989-10-12
GB8804188D0 (en) 1988-03-23
DK521389A (da) 1989-12-15
WO1989008095A1 (en) 1989-09-08
DE3879489D1 (de) 1993-04-22
JPH02503792A (ja) 1990-11-08

Similar Documents

Publication Publication Date Title
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
EP0221041A3 (de) Benzimidazolderivate, Verfahren zu deren Herstellung und ihre pharmazeutische Verwendung
GR3019315T3 (en) Use of nervonic acid and long chain fatty acids for the treatment of demyelinating disorders
DE58901401D1 (de) Pharmazeutische zubereitung zur behandlung des diabetes mellitus.
DE59410151D1 (de) Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
ATE99172T1 (de) Verwendung von acetyl-l-carnitin zur behandlung von katarakt, sowie pharmazeutische zusammensetzungen fuer eine derartige behandlung.
ATE55695T1 (de) Verwendung von defibrotid zur herstellung pharmazeutischer zusammensetzungen zur behandlung peripherer arteriopathien.
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
AU2159888A (en) Novel calcium supplements
DE3483338D1 (de) Pharmazeutische peptide, ihre herstellung und verwendung sowie zwischenprodukte.
ATE88633T1 (de) Verwendung von bestimmten calcium-citrate-malaten zur herstellung einer pharmazeutischen zubereitung fuer die behandlung von osteoporose.
HUT57204A (en) Process for producing 4-fluoro-2-///4-methoxy-2-pyridinyl/-methyl/-sulfinyl/-1h-benzimidazol with gastric acid secration-diminishing activity and pharmaceutical compositions containing them
ATE86965T1 (de) Pharmazeutische kompositionen zum behandeln von adrenoleukodystrophie.
GR890100563A (el) Προαγωγη της αναπτυξεως χοιρων.
ATE45090T1 (de) Pharmazeutische zusammensetzung in oralen darreichungsformen.
ATE73326T1 (de) Verwendung von l-carnitin zur herstellung eines arzneimittels zur behandlung von toxischen effekten, induziert durch die inhalation von halotan und anderen halogen enthaltenden allgemeinen anaesthetika.
RU96111879A (ru) Способ приготовления гомеопатических мягких лекарственных форм
UA15281A (uk) Спосіб лікуваhhя хроhічhої ішемічhої хвороби серця
ATE32514T1 (de) 3-(4'-aminobutylamino)-propylamino-bleomycinderivate, verfahren zur ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee